To the full analysis
Buyback calculator for Alibaba Health Information Technology
Alibaba Health Information Technology stock: dividend
0241.HKWhat Alibaba Health Information Technology Limited pays out, how dependable that has been over the years, and whether free cash flow carries it. A dividend paid out of substance rather than out of the business is not a good dividend.
Daily figure as of 13 Nov 2026
Alibaba Health Information Technology Limited currently pays no dividend.
Dividend dates and payments
Anyone holding the stock on the day before the ex-dividend date receives the dividend. Amounts are per share, before tax.
Last ex-dividend date
12 Aug 2026
$0.0285, paid 2 Sep 2026
Next ex-dividend date
not announced yet
Frequency
no data
All 1 payments of the last five years
| Ex-dividend date | Payment date | Dividend per share |
|---|---|---|
| 12 Aug 2026 | 2 Sep 2026 | $0.0285 |
Free cash flow and buybacks
| Fiscal year | Free cash flow | Share buybacks | Shares outstanding |
|---|---|---|---|
| 2026 | $184.1M | $0 | 16.20B |
| 2025 | $206.37M | $5.99M | 16.07B |
| 2024 | $158.52M | $15.68M | 14.09B |
| 2023 | $37.5M | $12.23M | 13.50B |
| 2022 | $61.4M | $2.48M | 13.48B |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = HK$7.8782, $1 = CN¥6.6683)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 17 Jan 2025)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.